Efficacy of an early intensification integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.

Investigates the impact of early intensification programs on patients with primary mediastinal large B cell lymphoma (MLCL) with sclerosis presenting with adverse prognostic factors. Example of early intensification programs; Manifestations of MLCL; Information on the prior therapy and disease status at autologous stem cell transplantation of several MLCL patients with sclerosis; Details on the disease-free survival of the patients.